Marcella Rietschel Selected Research

Nortriptyline (Aventyl)

1/2019	Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder.
1/2019	Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder.
10/2018	Genetic disposition to inflammation and response to antidepressants in major depressive disorder.
1/2016	Combining clinical variables to optimize prediction of antidepressant treatment outcomes.
4/2011	Changes in body weight during pharmacological treatment of depression.
12/2010	Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP.
6/2010	History of suicide attempts among patients with depression in the GENDEP project.
11/2009	Body weight as a predictor of antidepressant efficacy in the GENDEP project.
11/2009	Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project.
10/2009	Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcella Rietschel Research Topics

Disease

91	Schizophrenia (Dementia Praecox) 10/2022 - 04/2002
38	Bipolar Disorder (Manic Depressive Psychosis) 07/2022 - 04/2002
21	Alcoholism (Alcohol Abuse) 11/2021 - 07/2008
20	Mood Disorders (Mood Disorder) 01/2021 - 07/2002
18	Major Depressive Disorder (Major Depressive Disorders) 04/2022 - 02/2005
13	Mental Disorders (Mental Disorder) 01/2021 - 01/2004
9	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 11/2008
8	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2018 - 04/2007
7	Genetic Risk Score 07/2022 - 01/2017
6	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 04/2012
6	Depressive Disorder (Melancholia) 01/2020 - 09/2008
4	Drug-Related Side Effects and Adverse Reactions 12/2021 - 09/2009
4	Substance-Related Disorders (Drug Abuse) 01/2020 - 08/2013
4	Inflammation (Inflammations) 10/2018 - 05/2017
3	Wounds and Injuries (Trauma) 01/2022 - 01/2018
3	Sleep Deprivation 01/2020 - 12/2018
3	Obesity 12/2017 - 11/2009
3	Tobacco Use Disorder (Nicotine Dependence) 03/2016 - 08/2010
3	Body Weight (Weight, Body) 03/2013 - 11/2009
3	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2011 - 09/2009
3	Weight Gain 07/2011 - 09/2009
3	Panic Disorder (Panic Attack) 07/2006 - 06/2004
2	Disease Progression 12/2019 - 01/2013
2	Cognitive Dysfunction 01/2019 - 01/2017
2	Pain (Aches) 12/2015 - 03/2015
2	Fibrosis (Cirrhosis) 12/2015 - 01/2011
2	Anxiety Disorders (Anxiety Disorder) 01/2015 - 06/2014
2	Genetic Predisposition to Disease (Genetic Predisposition) 04/2012 - 01/2012
2	Neurobehavioral Manifestations 12/2010 - 03/2009

Drug/Important Bio-Agent (IBA)

18	Antidepressive Agents (Antidepressants)IBA 04/2022 - 09/2009
18	Biological ProductsIBA 01/2021 - 10/2002
12	Nortriptyline (Aventyl)FDA LinkGeneric 01/2019 - 03/2009
12	Escitalopram FDA Link 01/2019 - 03/2009
11	LithiumIBA 07/2022 - 01/2013
11	Antipsychotic Agents (Antipsychotics)IBA 03/2022 - 07/2002
10	Pharmaceutical PreparationsIBA 11/2021 - 07/2011
9	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2004
7	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016 - 10/2006
7	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 06/2015 - 11/2005
7	Neuregulin-1 (Neuregulin 1)IBA 05/2014 - 09/2006
6	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 05/2005
6	DysbindinIBA 04/2012 - 01/2003
5	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2014
5	ApolipoproteinsIBA 01/2021 - 01/2014
5	salicylhydroxamic acid (SHAM)IBA 01/2021 - 06/2015
5	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 09/2015 - 05/2005
5	Serotonin (5 Hydroxytryptamine)IBA 01/2012 - 07/2006
4	Proteins (Proteins, Gene)FDA Link 10/2019 - 07/2009
4	Protein Isoforms (Isoforms)IBA 10/2018 - 03/2010
4	Glutamic Acid (Glutamate)FDA Link 10/2018 - 10/2008
4	Dopamine (Intropin)FDA LinkGeneric 12/2017 - 09/2006
4	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2015 - 05/2004
4	Calcium Channels (Calcium Channel)IBA 07/2014 - 02/2014
3	Glutamate Receptors (Glutamate Receptor)IBA 01/2022 - 10/2008
3	Serotonin ReceptorsIBA 01/2020 - 11/2004
3	GhrelinIBA 01/2019 - 11/2017
3	C-Reactive ProteinIBA 10/2018 - 05/2017
3	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2018 - 04/2012
3	Transcription Factor 4IBA 07/2015 - 08/2009
3	Tryptophan HydroxylaseIBA 11/2014 - 01/2008
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2013 - 08/2005
3	NeurocanIBA 09/2012 - 03/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 09/2006
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2008 - 04/2004
2	HLA-DQB1 antigen (HLA DQB1)IBA 12/2021 - 01/2021
2	Clozapine (Clozaril)FDA LinkGeneric 12/2021 - 01/2019
2	Ethanol (Ethyl Alcohol)IBA 01/2021 - 05/2017
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2020 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 10/2019 - 03/2013
2	Hormones (Hormone)IBA 01/2019 - 01/2019
2	Oxidoreductases (Dehydrogenase)IBA 01/2019 - 07/2011
2	EnzymesIBA 01/2019 - 07/2006
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2019 - 04/2011
2	ProlactinIBA 01/2019 - 01/2009
2	LeptinIBA 01/2019 - 12/2017
2	CalciumIBA 01/2018 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2017 - 06/2011
2	Opioid Analgesics (Opioids)IBA 03/2016 - 08/2015
2	Serine (L-Serine)FDA Link 01/2016 - 08/2008
2	N-Methylaspartate (NMDA)IBA 01/2016 - 09/2013
2	P-2 (P 2)IBA 11/2015 - 06/2012
2	Dopa DecarboxylaseIBA 11/2014 - 07/2002
2	Butyric Acid (Butanoic Acid)IBA 10/2014 - 02/2007
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 03/2014 - 05/2007
2	Nicotine FDA Link 01/2014 - 08/2013
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 12/2013 - 08/2010
2	glutamate receptor delta 1IBA 12/2012 - 06/2009
2	3' Untranslated Regions (3' UTR)IBA 01/2012 - 04/2007
2	NeurograninIBA 10/2011 - 08/2009
2	catechol (pyrocatechol)IBA 09/2010 - 06/2004
2	TransferasesIBA 09/2010 - 06/2004
2	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 06/2010 - 11/2009
2	Clomipramine (Anafranil)FDA LinkGeneric 01/2009 - 07/2006
2	5-HT1A Serotonin ReceptorIBA 01/2009 - 06/2004
2	serine racemaseIBA 04/2007 - 04/2007
2	Phospholipases A2 (Phospholipase A2)IBA 08/2006 - 12/2003

Therapy/Procedure

4	Therapeutics 12/2021 - 05/2017
4	Transcranial Magnetic Stimulation 01/2019 - 06/2015
2	Self Administration (Administration, Self) 01/2019 - 11/2017
2	Behavior Control 01/2017 - 06/2015